Your browser doesn't support javascript.
loading
Breakthrough Clostridium difficile Infection in Cirrhotic Patients Receiving Rifaximin.
Reigadas, Elena; Alcalá, Luis; Gómez, Javier; Marín, Mercedes; Martin, Adoración; Onori, Raffaella; Muñoz, Patricia; Bouza, Emilio.
Afiliação
  • Reigadas E; Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón.
  • Alcalá L; Medicine Department, School of Medicine, Universidad Complutense de Madrid.
  • Gómez J; Instituto de Investigación Sanitaria Gregorio Marañón.
  • Marín M; Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón.
  • Martin A; Instituto de Investigación Sanitaria Gregorio Marañón.
  • Onori R; CIBER de Enfermedades Respiratorias (CIBERES CB06/06/0058), Spain.
  • Muñoz P; Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón.
  • Bouza E; Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón.
Clin Infect Dis ; 66(7): 1086-1091, 2018 03 19.
Article em En | MEDLINE | ID: mdl-29069372

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encefalopatia Hepática / Infecções por Clostridium / Antibioticoprofilaxia / Rifaximina / Cirrose Hepática / Antibacterianos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encefalopatia Hepática / Infecções por Clostridium / Antibioticoprofilaxia / Rifaximina / Cirrose Hepática / Antibacterianos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article